+Cy5 C0992 NA NA M
169 Ciliated Cell Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA
+Cy5 C0992 NA NA M
169 Ciliated Cell Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA
+Cy5 C0992 NA NA M
169 Ciliated Cell Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA
y n/d y
210 Cytokeratin peptide 18 C1399 M y n/d n/d
211 Cytokeratin peptide 19 C6930 M y n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 M y n/d
KRT18 NP_954657.1 M y n/d n/d
211 Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 1611 DAP NP_004385.1 M y
PI3 Kinase
Monoclonal Antibody
Anti-PI3 Kinase, p85, N-SH3 AB6 H M IP WB IC Pur M IgG1κ 100 µg 05-212
Anti-PI3 Kinase, p85, N-SH2 UB93-3 H M R IP WB Sup M IgG 200 µL 05-217
Anti-PI3 Kinase
KRT18 NP_954657.1 M y n/d n/d
211 Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 1611 DAP NP_004385.1 M y